Skip to content

Performance de l’équation MDRD corrigée par la cimétidine chez le patient transplanté rénal

Performance de l’équation MDRD corrigée par la cimétidine chez le patient transplanté rénal

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2006-005294-22-FR
Enrollment
Unknown
Registered
2006-12-07
Start date
2006-12-29
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Estimating glomerular filtration rate in kidney transplantation: a comparison between inulin clearance and MDRD equation with cimetidin (block of secretion renal tubule) MedDRA version: 8.1 Level: PT Classification code 10018355 Term: Glomerular filtration rate

Interventions

Trade Name: Cimetidine arrow Pharmaceutical Form: Tablet

Sponsors

CHU Saint-Etienne
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - > 18 years - Kidney transplantation > 1 year - Patient with immunosuppressant treatment of TACROLIMUS (PROGRAF?) - Creatinine clearance > 30 ml/min/1,73m2 within 3 months before inclusion - Written informed consent - Patient affiliated to social insurance Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: - Unstable renal fonction defined by serum creatinine (J0) > 25% serum creatinine realised in 3 mois - Treatment: Bactrim®, Fansidar®, Cimetidine arrow® withing the week before inclusion - Contraindication listed in in the labeling of Cimetidine arrow® (absolue, relative et médicaments nécessitant des précautions d’emploi cf ficheVidal en annexe 3) - Last residual rate of Tacrolimus > 12 ng/ml. - Treatment : carvedilol, phenytoïne (intercation with cimetidine) - Serious hepatic insuffisancy

Design outcomes

Primary

MeasureTime frame
Main Objective: compare performance of inulin clearance and MDRD with or no block of secretion renal tubule with cimetidin, in kidney transplantation;Secondary Objective: ? Performance of different prediction equations for estimating renal function in kidney transplantation with or no block of secretion renal tubule with cimetidin : - Walser equation - Nankivell equation - Cockcroft and Gault equation ? comparison between inulin clearance and cystatin C ;Primary end point(s): Performance of different prediction equation : accuracy -30%, ie defined by proportion of patients with a estimation of glomerular filtration glomerular is include in - 30 % et + 30 % of inulin clearance value.

Countries

France

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026